Cargando…
Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062573/ https://www.ncbi.nlm.nih.gov/pubmed/35411701 http://dx.doi.org/10.1111/cns.13841 |
| _version_ | 1784698974473551872 |
|---|---|
| author | Hoepner, Robert Kamm, Christian P Friedli, Christoph Salmen, Anke Chan, Andrew |
| author_facet | Hoepner, Robert Kamm, Christian P Friedli, Christoph Salmen, Anke Chan, Andrew |
| author_sort | Hoepner, Robert |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9062573 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90625732022-05-03 Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? Hoepner, Robert Kamm, Christian P Friedli, Christoph Salmen, Anke Chan, Andrew CNS Neurosci Ther Letters to the Editor John Wiley and Sons Inc. 2022-04-12 /pmc/articles/PMC9062573/ /pubmed/35411701 http://dx.doi.org/10.1111/cns.13841 Text en © 2022 The Authors. CNS Neuroscience & Therapeutics Published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Hoepner, Robert Kamm, Christian P Friedli, Christoph Salmen, Anke Chan, Andrew Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? |
| title | Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? |
| title_full | Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? |
| title_fullStr | Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? |
| title_full_unstemmed | Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? |
| title_short | Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? |
| title_sort | is covid‐19 severity associated with reduction in t lymphocytes in anti‐cd20‐treated people with multiple sclerosis or neuromyelitis optica spectrum disorder? |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062573/ https://www.ncbi.nlm.nih.gov/pubmed/35411701 http://dx.doi.org/10.1111/cns.13841 |
| work_keys_str_mv | AT hoepnerrobert iscovid19severityassociatedwithreductionintlymphocytesinanticd20treatedpeoplewithmultiplesclerosisorneuromyelitisopticaspectrumdisorder AT kammchristianp iscovid19severityassociatedwithreductionintlymphocytesinanticd20treatedpeoplewithmultiplesclerosisorneuromyelitisopticaspectrumdisorder AT friedlichristoph iscovid19severityassociatedwithreductionintlymphocytesinanticd20treatedpeoplewithmultiplesclerosisorneuromyelitisopticaspectrumdisorder AT salmenanke iscovid19severityassociatedwithreductionintlymphocytesinanticd20treatedpeoplewithmultiplesclerosisorneuromyelitisopticaspectrumdisorder AT chanandrew iscovid19severityassociatedwithreductionintlymphocytesinanticd20treatedpeoplewithmultiplesclerosisorneuromyelitisopticaspectrumdisorder |